MX344015B - Vacunas y diagnostico para torque teno virus porcino. - Google Patents

Vacunas y diagnostico para torque teno virus porcino.

Info

Publication number
MX344015B
MX344015B MX2012002273A MX2012002273A MX344015B MX 344015 B MX344015 B MX 344015B MX 2012002273 A MX2012002273 A MX 2012002273A MX 2012002273 A MX2012002273 A MX 2012002273A MX 344015 B MX344015 B MX 344015B
Authority
MX
Mexico
Prior art keywords
porcino
vaccines
diagnosis
torque teno
teno virus
Prior art date
Application number
MX2012002273A
Other languages
English (en)
Other versions
MX2012002273A (es
Inventor
Huang Yaowei
Meng Xiang-Jin
Original Assignee
Virginia Tech Intellectual Properties Inc *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Tech Intellectual Properties Inc * filed Critical Virginia Tech Intellectual Properties Inc *
Publication of MX2012002273A publication Critical patent/MX2012002273A/es
Publication of MX344015B publication Critical patent/MX344015B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

La presente invención se refiere a una composición inmunogénica caracterizada porque comprende porque comprende un polipéptido que comprende los aminoácidos 310-365 de SEQ ID NO: 16 expresado por un plásmido biológicamente funcional o vector de expresión de baculovirus. La composición inmunogénica porque además comprende un adyuvante.
MX2012002273A 2009-08-21 2010-08-23 Vacunas y diagnostico para torque teno virus porcino. MX344015B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23583309P 2009-08-21 2009-08-21
US31651910P 2010-03-23 2010-03-23
US12/861,378 US9228242B2 (en) 2009-08-21 2010-08-23 Porcine torque teno virus vaccines and diagnosis
PCT/US2010/046330 WO2011031438A2 (en) 2009-08-21 2010-08-23 Porcine torque teno virus vaccines and diagnosis

Publications (2)

Publication Number Publication Date
MX2012002273A MX2012002273A (es) 2012-09-07
MX344015B true MX344015B (es) 2016-12-02

Family

ID=43605547

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012002273A MX344015B (es) 2009-08-21 2010-08-23 Vacunas y diagnostico para torque teno virus porcino.

Country Status (20)

Country Link
US (2) US9228242B2 (es)
EP (2) EP2467484A4 (es)
JP (3) JP6002036B2 (es)
KR (3) KR20140110101A (es)
CN (2) CN102712930B (es)
AU (1) AU2010292848B2 (es)
BR (1) BR112012003844B1 (es)
CA (1) CA2771771C (es)
CL (4) CL2012000452A1 (es)
CO (1) CO6531416A2 (es)
ES (1) ES2767781T3 (es)
HK (1) HK1249111A1 (es)
IN (1) IN2012DN02305A (es)
MX (1) MX344015B (es)
PH (2) PH12012500359A1 (es)
PL (1) PL2851428T3 (es)
RU (1) RU2553223C2 (es)
SG (1) SG178512A1 (es)
WO (1) WO2011031438A2 (es)
ZA (1) ZA201201949B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3278122B2 (ja) 1993-06-11 2002-04-30 自動車電機工業株式会社 電磁継電器の製造方法
CN102712930B (zh) 2009-08-21 2017-06-13 弗吉尼亚理工大学知识产权公司 猪细环病毒的疫苗和诊断
EP2530170A1 (en) * 2011-05-31 2012-12-05 Intervet International BV Torque Teno virus diagnostics
CN102590503B (zh) * 2012-01-20 2015-02-25 四川农业大学 一种猪细环病毒ⅱ型抗体间接阻断elisa检测试剂盒
CN103376317B (zh) * 2012-04-12 2015-11-18 徐超 不同疫苗适用性与经济性的现场判定方法
EP2653562A1 (en) 2012-04-20 2013-10-23 Institut Pasteur Anellovirus genome quantification as a biomarker of immune suppression
CN103014056B (zh) * 2012-11-23 2014-12-10 广东海大畜牧兽医研究院有限公司 一种猪Ⅱ型细环病毒TTSuV2-ORF1截短蛋白的酵母表达及应用
CN102998453B (zh) * 2012-11-23 2014-10-08 广东海大畜牧兽医研究院有限公司 一种猪Ⅰ型细环病毒TTSuV1抗体间接ELISA诊断试剂盒及其制备方法
CN103235121B (zh) * 2013-03-18 2015-08-05 江苏省农业科学院 一种检测猪输血传播病毒2型抗体的间接elisa试剂盒
CN108431024A (zh) * 2015-10-16 2018-08-21 堪萨斯州立大学研究基金会 猪3型圆环病毒免疫原性组合物以及其制备和使用方法
CN107604098A (zh) * 2017-11-03 2018-01-19 福建省农业科学院畜牧兽医研究所 用于检测鸽TTV的EvaGreen实时荧光定量PCR引物及试剂盒
CN109061161B (zh) * 2018-11-14 2019-02-15 湖南省植物保护研究所 用于检测辣椒脉黄病毒的检测试剂盒及其应用
MX2022015802A (es) * 2020-06-12 2023-03-28 Flagship Pioneering Innovations V Inc Construcciones de anellovirus en tandem.
US20230340527A1 (en) * 2020-06-12 2023-10-26 Flagship Pioneering Innovations V, Inc. Baculovirus expression systems
KR20230041686A (ko) * 2020-06-17 2023-03-24 플래그쉽 파이어니어링 이노베이션스 브이, 인크. 아넬로바이러스를 확인 및 특징화하는 방법 및 이의 용도
CA3206361A1 (en) * 2020-12-23 2022-06-30 Flagship Pioneering Innovations V, Inc. In vitro assembly of anellovirus capsids enclosing rna

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1061377C (zh) * 1996-12-13 2001-01-31 中国预防医学科学院病毒学研究所 能用于包装重组腺病毒伴随病毒的单疱病毒载体及其用途
CN1704119A (zh) * 2004-05-28 2005-12-07 上海佳牧生物制品有限公司 猪细小病毒病油乳剂灭活疫苗
BRPI0717507A2 (pt) * 2006-10-05 2016-10-04 Cerebus Biolog Inc métodos para tratar, prevenir e diagnosticar infecção ttv de porcine
AU2009303845B2 (en) * 2008-10-16 2013-09-12 Zoetis Llc Torque teno virus (TTV) isolates and compositions
CN102712930B (zh) 2009-08-21 2017-06-13 弗吉尼亚理工大学知识产权公司 猪细环病毒的疫苗和诊断

Also Published As

Publication number Publication date
EP2851428B1 (en) 2019-04-10
CA2771771C (en) 2018-09-11
CL2014003563A1 (es) 2015-04-17
JP6002036B2 (ja) 2016-10-05
KR20140127903A (ko) 2014-11-04
JP6126176B2 (ja) 2017-05-10
CL2012000452A1 (es) 2013-07-05
RU2553223C2 (ru) 2015-06-10
MX2012002273A (es) 2012-09-07
CN102712930B (zh) 2017-06-13
EP2851428A2 (en) 2015-03-25
HK1249111A1 (zh) 2018-10-26
AU2010292848B2 (en) 2014-11-27
CL2014003561A1 (es) 2015-04-24
WO2011031438A3 (en) 2011-06-30
US20110045019A1 (en) 2011-02-24
EP2851428A3 (en) 2015-04-29
JP2013502229A (ja) 2013-01-24
CN107522775A (zh) 2017-12-29
ES2767781T3 (es) 2020-06-18
CA2771771A1 (en) 2011-03-17
KR20140110101A (ko) 2014-09-16
RU2012110303A (ru) 2013-09-27
US9228242B2 (en) 2016-01-05
CN102712930A (zh) 2012-10-03
KR101721090B1 (ko) 2017-03-29
PL2851428T3 (pl) 2019-12-31
JP2015221819A (ja) 2015-12-10
JP2017171663A (ja) 2017-09-28
SG178512A1 (en) 2012-03-29
US9897605B2 (en) 2018-02-20
US20160216263A1 (en) 2016-07-28
BR112012003844A2 (pt) 2016-11-16
AU2010292848A1 (en) 2012-04-12
PH12012500359A1 (en) 2012-10-22
KR101640062B1 (ko) 2016-07-18
CO6531416A2 (es) 2012-09-28
IN2012DN02305A (es) 2015-08-21
WO2011031438A9 (en) 2011-08-18
EP2467484A2 (en) 2012-06-27
ZA201201949B (en) 2013-05-29
KR20120063489A (ko) 2012-06-15
CL2014003562A1 (es) 2015-04-24
BR112012003844B1 (pt) 2021-05-04
EP2467484A4 (en) 2013-06-12
PH12016502013A1 (en) 2023-02-27
WO2011031438A2 (en) 2011-03-17

Similar Documents

Publication Publication Date Title
MX344015B (es) Vacunas y diagnostico para torque teno virus porcino.
PE20140986A1 (es) Proteinas de fusion y vacunas de combinacion que comprenden proteina e y pilina a de haemophilus influenzae
ES2673556T3 (es) Vacunas para el VHS-2
EP4241785A3 (en) Influenza virus vaccines and uses thereof
AR069882A1 (es) Circovirus porcino, molecula de acido nucleico aislada que lo codifica, composicion inmunogenica que lo comprende, vector que comprende por lo menos una molecula de acido nucleico exogena que codifica una proteina de circovirus porcino y metodos para inmunizar un cerdo contra la infeccion virica o e
NZ570553A (en) Immunogenic peptide sequences from influenza A and B and uses thereof for vaccines
BR112015000585A2 (pt) cepas mutantes de mycoplasma hyopneumoniae
ES2585328T3 (es) Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis
CL2012000447A1 (es) Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica.
UA110806C2 (uk) Мікобактеріальна антигенна композиція
MX358725B (es) Antigenos prostaticos de consenso, molecula de acido nucleico que los codifica y vacuna y usos que los comprenden.
WO2008124646A3 (en) Use of amyloid proteins as vaccine scaffolds
MX2008016036A (es) Vacuna viral recombinante.
WO2010019262A3 (en) Polyvalent vaccine
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
WO2013020722A3 (en) Composition comprising small peptide as amyloid beta mimotope and adjuvant for use as vaccine against alzheimer's disease
MX2011008649A (es) Vacuna contra el virus del dengue inactivado con un adyuvante libre de aluminio.
MY159543A (en) Recombinant avian influenza vaccine and uses thereof
AR080111A1 (es) Metodos y composiciones de inmunizacion
AR128395A2 (es) Péptidos novedosos capaces de inducir la formación de anticuerpos contra pcsk9
NZ596501A (en) Casb7439 constructs
MX363149B (es) Vacunas de nucleoproteina de la influenza.
BR112013021870A2 (pt) vacina contra dengue tetravalente e bivalente mista
AR082281A1 (es) Vectores de parapoxvirus
WO2013171661A3 (en) Adjuvant formulations and methods

Legal Events

Date Code Title Description
FG Grant or registration